Literature DB >> 16238918

Erectile dysfunction as a marker for vascular disease.

Kevin L Billups1.   

Abstract

A body of evidence from basic science and clinical research is emerging to provide a compelling argument for endothelial dysfunction as a central etiologic factor in the development of atherosclerosis and systemic vascular diseases (hypertension, dyslipidemia, diabetes, ischemic heart disease, stroke, or claudication). Erectile dysfunction (ED) is another prevalent vascular disorder that, like cardiovascular disease, is now thought to be caused by endothelial dysfunction. In fact, a burgeoning literature is now available that suggests that ED may be an early marker for atherosclerosis, cardiovascular risk, and subclinical systemic vascular disease. The emerging awareness of ED as a barometer for vascular health and occult cardiovascular disease represents a unique opportunity for primary prevention of vascular disease in all men. Although the implications of this relationship for primary and secondary prevention of cardiovascular disease are not fully appreciated, the available literature makes a strong argument for the role of ED as an early marker for the development of significant cardiovascular risk factors and cardiovascular disease.

Entities:  

Mesh:

Year:  2005        PMID: 16238918     DOI: 10.1007/s11934-005-0039-9

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  28 in total

Review 1.  Platelets, oxidant stress and erectile dysfunction: an hypothesis.

Authors:  J Y Jeremy; G D Angelini; M Khan; D P Mikhailidis; R J Morgan; C S Thompson; K R Bruckdorfer; K M Naseem
Journal:  Cardiovasc Res       Date:  2000-04       Impact factor: 10.787

2.  Hypertension, anti-hypertensive drug therapy and erectile dysfunction in diabetes.

Authors:  P K Moulik; K J Hardy
Journal:  Diabet Med       Date:  2003-04       Impact factor: 4.359

Review 3.  NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence.

Authors: 
Journal:  JAMA       Date:  1993-07-07       Impact factor: 56.272

4.  Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panel.

Authors:  Kevin L Billups; Alan J Bank; Harin Padma-Nathan; Stuart Katz; Richard Williams
Journal:  J Sex Med       Date:  2005-01       Impact factor: 3.802

5.  Cessation of smoking rapidly decreases erectile dysfunction.

Authors:  A T Guay; J B Perez; G J Heatley
Journal:  Endocr Pract       Date:  1998 Jan-Feb       Impact factor: 3.443

6.  Association of type and duration of diabetes with erectile dysfunction in a large cohort of men.

Authors:  Constance G Bacon; Frank B Hu; Edward Giovannucci; Dale B Glasser; Murray A Mittleman; Eric B Rimm
Journal:  Diabetes Care       Date:  2002-08       Impact factor: 19.112

7.  Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation.

Authors:  Erin A Saltzman; Andre T Guay; Jerilynn Jacobson
Journal:  J Urol       Date:  2004-07       Impact factor: 7.450

8.  Sexual function in men older than 50 years of age: results from the health professionals follow-up study.

Authors:  Constance G Bacon; Murray A Mittleman; Ichiro Kawachi; Edward Giovannucci; Dale B Glasser; Eric B Rimm
Journal:  Ann Intern Med       Date:  2003-08-05       Impact factor: 25.391

9.  Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men.

Authors:  R Virag; P Bouilly; D Frydman
Journal:  Lancet       Date:  1985-01-26       Impact factor: 79.321

10.  Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial.

Authors:  Katherine Esposito; Francesco Giugliano; Carmen Di Palo; Giovanni Giugliano; Raffaele Marfella; Francesco D'Andrea; Massimo D'Armiento; Dario Giugliano
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272

View more
  6 in total

1.  Time-course changes of nLDL-induced erectile dysfunction.

Authors:  N Durmus; A Toylu; S Evcim; B C Soner; O Demir; E Kahraman; T Demir; B Irer; S Gidener; N Atabey; A Esen
Journal:  Int J Impot Res       Date:  2017-03-16       Impact factor: 2.896

Review 2.  Gonadal dysfunction in chronic kidney disease.

Authors:  Biff F Palmer; Deborah J Clegg
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

3.  Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain.

Authors:  Juan Carlos Torre-Alonso; Loreto Carmona; Mireia Moreno; Eva Galíndez; Jesús Babío; Pedro Zarco; Luis Linares; Eduardo Collantes-Estevez; Manuel Fernández Barrial; Juan Carlos Hermosa; Pablo Coto; Carmen Suárez; Raquel Almodóvar; Jesús Luelmo; Santos Castañeda; Jordi Gratacós
Journal:  Rheumatol Int       Date:  2017-04-07       Impact factor: 2.631

Review 4.  [Metabolic syndrome and erectile dysfunction. Epidemiologic associations and pathogenetic links].

Authors:  A Wirth; M Manning; H Büttner
Journal:  Urologe A       Date:  2007-03       Impact factor: 0.639

5.  Diagnosis and treatment patterns of Peyronie's disease among different racial, ethnic, and regional groups in the Veterans Affairs healthcare system.

Authors:  Sirpi Nackeeran; Isaac Zucker; Iakov Efimenko; Alexander Weber; Scott C Brown; Ranjith Ramasamy; Thomas Masterson
Journal:  Int J Impot Res       Date:  2022-09-23       Impact factor: 2.408

Review 6.  Endothelial Dysfunction, Erectile Deficit and Cardiovascular Disease: An Overview of the Pathogenetic Links.

Authors:  Federico De Leonardis; Gaia Colalillo; Enrico Finazzi Agrò; Roberto Miano; Andrea Fuschi; Anastasios D Asimakopoulos
Journal:  Biomedicines       Date:  2022-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.